Skip to main content
LYEL
NASDAQ Life Sciences

Ronde-Cel Shows 77% Complete Response Rate in 3L+ Lymphoma Ahead of ASH

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$11.76
Mkt Cap
$263.92M
52W Low
$7.195
52W High
$45
52W Position info
63% above low
Off High info
74% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

LYEL sits 63% above its 52-week low of $7.195.

Summary

Lyell disclosed updated ronde-cel data ahead of ASH 2026 (Dec 12-15), covering more than 80 patients across the pivotal 3L+ PiNACLE trial and the Phase 1/2 2L cohort. In 3L+, 44 response-evaluable patients showed a 91% overall response rate and 77% complete response rate, with median PFS not reached and estimated 24-month PFS of 54%. The 2L cohort posted 95% ORR and 76% CR among 37 evaluable patients. Safety looks clean on CRS — no Grade ≥3 events in either cohort — though Grade ≥3 ICANS hit 9% in both. This lands the same day as the $80M private placement at $10.77 per share, which funds the ronde-cel push; the data support that raise rather than change the story, and shares rose 35%. Full pivotal PiNACLE data are expected mid-2027, with BLA submission in the second half of 2027.

At the time of this announcement, LYEL was trading at $11.76 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $263.9M. The 52-week trading range was $7.20 to $45.00. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

LYEL - Latest Insights

LYEL
Nov 04, 2026, 4:17 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $14.74
Real-time Price: $13.80 info
Change: -$0.940 (-6%) info
Market Cap: $339.281M info
LYEL
Nov 04, 2026, 4:05 PM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $15.33
Real-time Price: $13.80 info
Change: -$1.53 (-10%) info
Market Cap: $339.281M info
LYEL
Nov 04, 2026, 9:05 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $11.76
Real-time Price: $13.80 info
Change: +$2.04 (+17%) info
Market Cap: $339.281M info
LYEL
Nov 04, 2026, 9:02 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $10.77
Real-time Price: $13.80 info
Change: +$3.03 (+28%) info
Market Cap: $339.281M info
LYEL
May 06, 2026, 4:22 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $20.85
Real-time Price: $13.80 info
Change: -$7.05 (-34%) info
Market Cap: $339.281M info